• Return to Headlines

Biogen Idec has the Highest Sales per Share in the Biotechnology Industry (BIIB, REGN, UTHR, AMGN, GILD)

By James Quinn

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Idec ranks highest with a sales per share of $45.06. Following is Regeneron Pharmaceuticals with a sales per share of $37.13. United Therapeutics ranks third highest with a sales per share of $30.33.

Amgen follows with a sales per share of $28.24, and Gilead Sciences rounds out the top five with a sales per share of $21.23.

SmarTrend recommended that subscribers consider buying shares of Biogen Idec on July 7th, 2016 as our technology indicated a new Uptrend was in progress when shares hit $247.44. Since that recommendation, shares of Biogen Idec have risen 25.9%. We continue to monitor Biogen Idec for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest sales per share Biogen Idec regeneron pharmaceuticals United Therapeutics Amgen Gilead Sciences